Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cyberkinetics gives BrainGate update:

This article was originally published in Clinica

Executive Summary

Cyberkinetics Neurotechnology Systems (Foxborough, Massachusetts) has presented additional data supporting the use of its BrainGate Neural Interface System. The system is designed to convert brain cell impulses to computer signals that can be used to control a variety of equipment. Dr John Donoghue, Cyberkinetics' co-founder and chief scientific officer, told the annual meeting of the Society for Neuroscience in Atlanta, Georgia, that significant progress has been achieved in the development of neural signal-control filters that improve the speed and accuracy of the patient's cursor control. These improvements have resulted in one patient, quadriplegic after a brain stem stroke, being able to operate a commercially available communication device as well as control a motorised wheelchair by thought alone. Preliminary data on the device was released at the American Spinal Cord Injury Association meeting earlier this year (see Clinica No 1214, p20).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel